Client Background A biotech scale-up developing a groundbreaking therapeutic treatment was at a pivotal stage in its growth. The company needed €7M in equity financing to advance its clinical trials and obtain regulatory approval for market entry. Despite strong scientific validation, navigating the highly specialized investor landscape was a major challenge. Challenge / Pain Points…
Silicon Valley Bank (SVB) is a financial services company that specializes in serving the needs of technology, life science, and venture capital companies. The bank was founded in 1983 and is headquartered in Santa Clara, California, in the heart of Silicon Valley.
Columbia Lake Partners (CLP) is a venture debt provider that offers growth loans to European early-stage and growth-stage technology companies. CLP also provides strategic guidance and support to its portfolio companies.
Kreos Capital is a private equity and venture debt firm that provides growth capital to companies in a variety of industries. The firm was founded in 1998 and has offices in London, Munich, and Stockholm. Kreos Capital focuses on providing growth capital to companies that are experiencing rapid expansion, often in the form of venture debt financing.
Venture debt, also known as venture lending, is a type of financing that is often used by startups to fund their growth and expansion. Unlike traditional debt, which is typically secured by collateral such as real estate or equipment, venture debt is typically unsecured and is based on the potential future success of the company.
